Caplin Point Laboratories Ltd, engaged in manufacturing and sourcing APIs, finished formulations, R&D, and clinical research with international presence across Latin America,
(CAPLIPOINT)
XNSE:CAPLIPOINT, XBOM:524742
Caplin Point Q1 FY26 Earnings Results
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of active pharmaceutical ingredients APIs, finished formulations, research and development, and
Caplin Point Laboratories Ltd Q4FY25; 20% rise in Profits
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin
Caplin Point Laboratories Ltd Q3FY25; 17% rise in Profits
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin
Caplin Point Laboratories Ltd Q2FY25; 13% rise in Profits
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin
Caplin Point Laboratories Ltd Q4FY24; 20% rise in Profits
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin
Caplin Point Laboratories: Navigating Successes and Facing Challenges in Pharmaceutical Expansion.
Company Description: Caplin Point Laboratories, established in 1990, has evolved into a leading pharmaceutical company with a diverse product range, specializing in
Caplin Point Laboratories Ltd Q4FY23; 25% rise in Profits
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin
Caplin Point Laboratories Ltd Q1FY24; 21% rise in Profits
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin
Caplin Point Laboratories Ltd. (NSE: CAPLIPOINT): Q3FY23 Results Out; Total Income rise 15% YoY
Caplin Point Laboratories Ltd. (NSE: CAPLIPOINT) is a pharmaceutical company based in India. It is engaged in the development, manufacture, and marketing